FTC Sues Prescription Drug Middlemen for Artificially Inflating …
WEB7 hours ago · The FTC alleges that the three PBMs created a perverse drug rebate system that prioritizes high rebates from drug manufacturers, leading to artificially inflated insulin list prices.
F.T.C. Accuses Drug Middlemen of Inflating Insulin Prices
WEB7 hours ago · The Federal Trade Commission said on Friday that it had taken legal action against the three largest pharmacy benefit managers, accusing the drug middlemen of inflating insulin prices and...
Federal Trade Commission accuses three drug middlemen of …
WEB6 hours ago · The FTC accused the "Big Three" pharmacy benefit managers (PBMs) — UnitedHealth Group's Optum Rx, CVS Health's Caremark and Cigna's Express Scripts — of "engaging in anticompetitive and unfair...
Federal Trade Commission sues largest drug middlemen for …
WEB7 hours ago · The Federal Trade Commission took action Friday against the three largest pharmacy benefit managers, accusing the companies of artificially inflating insulin list prices that resulted in patients...
Drug middlemen illegally drive up the cost of insulin, FTC says
WEB4 hours ago · Federal regulators are accusing the country's three largest pharmacy benefit managers of illegally driving up the cost of insulin in the U.S., while making it harder for patients to obtain...
FTC sues drug middlemen for allegedly inflating insulin prices
WEB7 hours ago · The FTC has been investigating PBMs since 2022. The agency's suit argues that the three PBMs have created a "perverse" drug rebate system that prioritizes high rebates from drugmakers, which...
FTC Releases Interim Staff Report on Prescription Drug Middlemen
WEBThe Federal Trade Commission today published an interim report on the prescription drug middleman industry that underscores the impact pharmacy benefit managers (PBMs) have on the accessibility and affordability of prescription drugs.
FTC sues CVS, Cigna, UnitedHealth PBMs over insulin prices - STAT
WEB7 hours ago · The U.S. Federal Trade Commission filed a lawsuit against the largest pharmacy benefit managers and their group purchasing organizations for allegedly anticompetitive practices that...
FTC Deepens Inquiry into Prescription Drug Middlemen
WEBMay 17, 2023 · As part of its ongoing inquiry into pharmacy benefit managers (PBMs) and their impact on the accessibility and affordability of prescription drugs, the Federal Trade Commission has issu.
F.T.C. Slams Middlemen for High Drug Prices - The New York Times
WEBJul 9, 2024 · The Federal Trade Commission on Tuesday sharply criticized pharmacy benefit managers, saying in a scathing 71-page report that “these powerful middlemen may be profiting by inflating drug costs...